Welcome to the Breast Surgery update produced by the Library & Knowledge Service at East Cheshire NHS Trust
Tuesday 24 August 2010
The Lancet Vol 376 Iss 9737 2010
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial Andrew Tutt et al. pg. 235 - 245 Abstract only
